You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

CLINICAL TRIALS PROFILE FOR SHR4640


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for SHR4640

Trial ID Title Status Sponsor Phase Summary
NCT02815839 ↗ Single Dose Study of SHR4640 in Healthy Subjects Completed Jiangsu HengRui Medicine Co., Ltd. Phase 1 The objective of the study is to assess the safety, tolerance, food effect, pharmacokinetic and pharmacodynamic properties of single dose adminstration of SHR4640 in healthy volunteers.
NCT02890966 ↗ Multiple Dose Study of SHR4640 in Healthy Subjects Completed Jiangsu HengRui Medicine Co., Ltd. Phase 1 The objective of the study is to assess the tolerance, pharmacokinetic and pharmacodynamic properties of multiple dose adminstration of SHR4640 in healthy volunteers.
NCT03015948 ↗ A Single Dose Study of SHR4640 in Healthy Male Volunteers Completed Atridia Pty Ltd. Phase 1 This is a single-center, randomized, double-blind, placebo-controlled, single ascending-dose Phase I trial.
NCT03131583 ↗ The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout Completed Jiangsu HengRui Medicine Co., Ltd. Phase 1 The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640, Febuxostat and Colchicine interaction in patients with gout.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for SHR4640

Condition Name

Condition Name for
Intervention Trials
Gout 5
Hyperuricemia 5
Gout; Hyperuricemia 2
Primary Gout 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Hyperuricemia 8
Gout 4
Arthritis, Gouty 1
Liver Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SHR4640

Trials by Country

Trials by Country for
Location Trials
China 10
Australia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SHR4640

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 2
Phase 2 3
Phase 1 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 7
Not yet recruiting 3
Unknown status 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SHR4640

Sponsor Name

Sponsor Name for
Sponsor Trials
Jiangsu HengRui Medicine Co., Ltd. 14
Atridia Pty Ltd. 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.